- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| Fr | Rubico announces 1-for-30 reverse stock split effective December 2 | ||
| Fr | Deere stock rating reaffirmed at Buy by UBS on 2027 recovery outlook | ||
| Fr | UBS raises Dillard's stock price target to $460 despite maintaining Sell rating | ||
| Fr | Rosenblatt lowers Netflix stock price target to $152 from $153, keeps Buy | ||
| Fr | Grupo Televisa stock price target raised to $10 by Benchmark on carriage deal | ||
| Fr | SGHC stock price target lowered to $17 by Benchmark on UK tax hikes | ||
| Fr | Investec Bank reports 2.4% drop in adjusted operating profit for H1 | ||
| Fr | Nidec Q2 2025 presentation slides: Operating profit plunges 82.5% amid accounting scandal | ||
| Fr | Vuzix receives $1 million in smart glasses orders from major retailer | ||
| Fr | Cushman & Wakefield completes redomiciliation from UK to Bermuda | ||
| Fr | ScanTech AI files restated financials amid Nasdaq compliance efforts | ||
| Fr | Gentex declares $0.12 quarterly dividend payable in January | ||
| Fr | Energy Monster schedules EGM to vote on going-private merger | ||
| Fr | Bayview completes $1.3 billion acquisition of Guild Holdings | ||
| Fr | Hungarian export bank completes capital injection into IHT Informatika | ||
| Fr | PACSCo delays 2025 annual accounts to December | ||
| Fr | JPMorgan upgrades Mitsubishi UFJ stock rating to Overweight on fee income growth | ||
| Fr | JPMorgan upgrades Sumitomo Mitsui Financial Group stock rating on yen outlook | ||
| Fr | Desjardins initiates coverage on OceanaGold stock with Buy rating | ||
| Fr | Jefferies downgrades Hamamatsu Photonics stock to Hold on slow profit recovery | ||
| Fr | Kubota stock rating upgraded to Buy at UBS on improved profitability outlook | ||
| Fr | Alamos Gold stock initiated with Buy rating by Desjardins on Canadian growth | ||
| Fr | Desjardins initiates Kinross Gold stock with Buy rating on strong cash flow | ||
| Fr | Desjardins initiates coverage on K92 Mining stock with Buy rating | ||
| Fr | Neurocrine Bio. stock jumps as rival drug faces modest Medicare price cut |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .